How much turkesterone do studies use, and how often?
| Trial | Dose and schedule | People | Length |
|---|---|---|---|
| Harris and colleagues, Muscles, 2024 | 1000 mg (with 1000 mg cellulose placebo) or 2000 mg by mouth, one dose per visit, against 2000 mg cellulose placebo, in a cross-over design1 | Eleven apparently healthy, recreationally active men aged 18 to 351 | Single doses, approximately 7 days or more apart1 |
| Crisanti and colleagues, 2025 | One capsule daily of Turk Builder, a turkesterone-containing product, strength not stated, against one capsule daily of cellulose placebo2 | Twenty-four healthy young university participants, 12 male and 12 female2 | Four weeks2 |
No label or regulator located sets a turkesterone dose; the trial by Harris and colleagues (Muscles, 2024) gave eleven healthy men single oral doses of 1000 mg or 2000 mg, and its authors write that most manufacturers recommend 1000 mg a day and suggest not exceeding 2000 mg a day.1
Doses used in human trials
The table is set at the top of the page
Two human turkesterone trials were located in PubMed and ClinicalTrials.gov listed none: one trial of single doses and one of a capsule whose strength is not stated. The Harris trial gave turkesterone by mouth, in the morning an hour before testing.1
In the Harris trial neither dose significantly changed resting metabolic rate or IGF-1 against placebo, though IGF-1 rose non-significantly with both doses.1 Its authors report no adverse effect on heart rate, blood pressure or self-reported gastrointestinal tolerability, and say a single-dose design cannot be extrapolated to longer-term outcomes.1 Crisanti and colleagues found no evidence that the turkesterone-containing product affected body composition, handgrip strength, mood or sleep over four weeks, and note a limited sample and short duration.2 Nothing located states a cycle length or an on and off scheme, and no turkesterone trial located ran longer than four weeks.
What labels and regulators say
Searches of DailyMed and ClinicalTrials.gov located no turkesterone label or registered trial, and no label or regulator page located sets a maximum dose. The 1000 mg a day and 2000 mg a day figures are second hand: the Harris authors write that most manufacturers recommend 1000 mg/day while suggesting not to exceed 2000 mg/day, and the maker pages could not be fetched to check this.1 The US Department of Defense's Operation Supplement Safety page says there is little to no information on the safety of ecdysterone and turkesterone as supplement ingredients, and that human evidence is a few small studies with inconsistent results.3 In December 2023 the Greek medicines organisation (EOF) banned the sale and distribution of a turkesterone supplement from Swedish Supplements because it contains Ajuga turkestanica, which it classes as an unapproved novel food (document in Greek).4
Frequently asked questions
What strengths is turkesterone sold in?
Capsule and powder strengths were not located, because the maker and retailer pages refused the request.
How is turkesterone powder mixed?
No mixing or dissolving instruction turned up in PubMed or DailyMed, and the maker pages refused the request. In the Harris trial each dose was placed in a nontransparent paper cup and taken with four ounces of water.1
How is turkesterone stored, before or after mixing?
No storage condition turned up in DailyMed, maker pages or the saved trial and review texts.
Is there a U-100 syringe mark for turkesterone?
No solution or injectable product with a concentration turned up, and every human trial gave it orally, so no syringe mark applies.1
References
- Muscles (MDPI). The Effects of Multiple Acute Turkesterone Doses on Indirect Measures of Hypertrophy and Metabolic Measures: A Preliminary Investigation. 2024. pmc.ncbi.nlm.nih.gov
- PMC. The effects of an ecdysteroid supplement on indices of physical and mental performance. 2025. pmc.ncbi.nlm.nih.gov
- Operation Supplement Safety (US Department of Defense). Ecdysterone and Turkesterone Dietary Supplements. opss.org
- EOF (Greek National Organization for Medicines). ΕΛΛΗΝΙΚΗ ΔΗΜΟΚΡΑΤΙΑ. eof.gr
- PubMed. Ecdysteroids as non-conventional anabolic agent: performance enhancement by ecdysterone supplementation in humans. 2019. pubmed.ncbi.nlm.nih.gov
- J Int Soc Sports Nutr. Effects of Methoxyisoflavone, Ecdysterone, and Sulfo-Polysaccharide Supplementation on Training Adaptations in Resistance-Trained Males. 2006. pmc.ncbi.nlm.nih.gov
- J Int Soc Sports Nutr. How reliable is the labeling of a commercial phytosteroid product? A 12-week randomized double-blind training study. 2025. pmc.ncbi.nlm.nih.gov
- PubMed. A Phase 1 study for safety and pharmacokinetics of BIO101 (20-hydroxyecdysone) in healthy young and older adults. 2023. pubmed.ncbi.nlm.nih.gov
- J Cachexia Sarcopenia Muscle. A Phase 1 study for safety and pharmacokinetics of BIO101 (20‐hydroxyecdysone) in healthy young and older adults. 2023. pmc.ncbi.nlm.nih.gov